chitosan has been researched along with Haemorrhagic Septicaemia, Viral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dar, SA; Jeong, HJ; Jung, SJ; Kole, S; Shin, SM | 1 |
| Jung, MH; Jung, SJ; Kim, T | 1 |
| Cho, SH; Jung, SJ; Kole, S; Kwak, IS; Shin, SM | 1 |
| Jung, SJ; Kim, WS; Kole, S; Lee, J; Qadiri, SSN; Shin, SM | 1 |
| Arnemo, M; Dios, S; Evensen, Ø; Gjøen, T; Griffiths, GW; Kavaliauskis, A; Kim, SH; Novoa, B; Speth, M; Ulanova, L | 1 |
| Arnemo, M; Estepa, A; Gjøen, T; Griffiths, G; Kavaliauskis, A; Lagos, L; Rishovd, AL; Speth, M | 1 |
1 trial(s) available for chitosan and Haemorrhagic Septicaemia, Viral
| Article | Year |
|---|---|
Potential Efficacy of Chitosan-Poly (Lactide-Co-Glycolide)-Encapsulated Trivalent Immersion Vaccine in Olive Flounder (
Topics: Animals; Antigens, Viral; Chitosan; Ciliophora Infections; Complement C3; Cytokines; Fish Diseases; Flounder; Gene Expression; Hemorrhagic Septicemia, Viral; Immunoglobulins; Kidney; Oligohymenophorea; Polylactic Acid-Polyglycolic Acid Copolymer; Spleen; Streptococcal Infections; Streptococcus; Toll-Like Receptors; Treatment Outcome; Viral Vaccines | 2021 |
5 other study(ies) available for chitosan and Haemorrhagic Septicaemia, Viral
| Article | Year |
|---|---|
Saponin and chitosan-based oral vaccine against viral haemorrhagic septicaemia virus (VHSV) provides protective immunity in olive flounder (Paralichthys olivaceus).
Topics: Animals; Body Weight; Chitosan; Fish Diseases; Flounder; Hemorrhagic Septicemia, Viral; Novirhabdovirus; Saponins; Viral Vaccines | 2022 |
Efficacy of Chitosan-PLGA encapsulated trivalent oral vaccine against viral haemorrhagic septicemia virus, Streptococcus parauberis, and Miamiensis avidus in olive flounder (Paralichthys olivaceus).
Topics: Animals; Chitosan; Fish Diseases; Flounder; Hemorrhagic Septicemia; Hemorrhagic Septicemia, Viral; Novirhabdovirus; Oligohymenophorea; Streptococcus; Toll-Like Receptor 2; Viral Vaccines | 2022 |
Nanoencapsulation of inactivated-viral vaccine using chitosan nanoparticles: Evaluation of its protective efficacy and immune modulatory effects in olive flounder (Paralichthys olivaceus) against viral haemorrhagic septicaemia virus (VHSV) infection.
Topics: Animals; Biocompatible Materials; Chitosan; Drug Compounding; Fish Diseases; Flatfishes; Flounder; Hemorrhagic Septicemia, Viral; Nanocapsules; Nanoparticles; Novirhabdovirus; Random Allocation; Vaccines, Inactivated; Viral Vaccines | 2019 |
Use of Poly(I:C) Stabilized with Chitosan As a Vaccine-Adjuvant Against Viral Hemorrhagic Septicemia Virus Infection in Zebrafish.
Topics: Adjuvants, Immunologic; Animals; Cells, Cultured; Chitosan; Head Kidney; Hemorrhagic Septicemia, Viral; Novirhabdovirus; Poly I-C; Polynucleotides; Viral Vaccines; Zebrafish | 2015 |
Protective effect of a recombinant VHSV-G vaccine using poly(I:C) loaded nanoparticles as an adjuvant in zebrafish (Danio rerio) infection model.
Topics: Adjuvants, Immunologic; Animals; Aquaculture; Cells, Cultured; Chitosan; Hemorrhagic Septicemia, Viral; Immunity; Leukocytes; Nanoparticles; Novirhabdovirus; Poly I-C; Vaccines, Synthetic; Viral Vaccines; Zebrafish | 2016 |